Promoting Healthy Pregnancy

Antepartum Overview and Nurse Roles

  • Definition of Antepartum: This period begins with conception and concludes with the onset of labor.

  • Nursing Responsibilities:

    • Answering patient questions.

    • Providing emotional and clinical support.

    • Conducting assessments through history taking, physical examinations, and diagnostic testing.

Pregnancy Terminology and Acronyms

  • Gravida: Refers to the total number of times a woman has been pregnant, regardless of the duration or outcome.

  • Para: Refers to a woman who has produced a viable infant, regardless of whether the fetus was alive at birth.

  • Viability: The specific point in a pregnancy at which the fetus could theoretically survive outside the mother’s womb.

  • GTPAL Acronym Breakdown:

    • G (Gravida): The total number of pregnancies, regardless of the outcome or the number of fetuses (e.g., twins count as one pregnancy).

    • T (Term): The number of term births delivered at 3737\,weeks’ gestation and beyond.

    • P (Preterm): The number of preterm births delivered after 2020\,weeks’ gestation but before 3737\,weeks’ gestation.

    • A (Abortion): The number of pregnancies that ended in a spontaneous or therapeutic abortion before 2020\,weeks’ gestation. These are included in the Gravida count.

    • L (Living): The number of currently living children.

Initial Prenatal Assessment and Diagnosis

  • Assessment Initiation: Usually begins when the woman suspects she is pregnant.

  • Diagnosis Methods:

    • Amenorrhea (absence of menstruation).

    • Testing of hCG levels.

    • Ultrasound (USUS) at 6 to 86\text{ to }8\,weeks.

    • Transvaginal ultrasound for early visualization.

  • Selection of Health Care Provider: Options include Family Physicians, Obstetrician-Gynecologists (OB/GYN), or Certified Nurse Midwives (CNM).

  • Determining Due Date: Uses Naegele’s rule to calculate the Estimated Date of Delivery (EDD).

Initial Patient History: Personal and Medical

  • Personal Information:

    • Age and relationship status.

    • Support systems (family, friends).

    • Race or ethnic background.

    • Occupation, economic level, and educational level.

    • History of emotional or physical abuse in the current relationship and assessment of current safety in the living situation.

  • Patient Medical History:

    • Previous surgical procedures and hospitalizations.

    • History of childhood diseases.

  • Family Medical History:

    • Occurrence of multiple births (twins, triplets).

    • History of birth defects or chromosomal abnormalities (e.g., Down syndrome).

    • History of chronic conditions: diabetes, hypertension, cardiovascular issues, bleeding disorders, thyroid disease, respiratory disease, or kidney disease.

    • Causes of death for deceased parents or siblings.

    • History of genetic disorders such as Cystic Fibrosis (CFCF) or Sickle Cell Disease.

Cultural, Religious, and Obstetrical History

  • Cultural and Spiritual Context:

    • Religious or spiritual beliefs affecting medical treatment acceptance.

    • Attitudes regarding the sex of the fetus.

    • Cultural preferences influencing obstetric care and the childbirth experience.

    • Preference for religious affiliation noted on the medical record.

  • Gynecological and Obstetric History:

    • Age of menses onset (menarche).

    • Menstrual cycle details: frequency and duration of flow.

    • History of dysmenorrhea (painful menstruation).

    • Infertility history and any fertility treatments received.

    • History of Sexually Transmitted Infections (STIsSTIs).

    • Date of the last Pap test.

    • History of contraceptive use.

    • Detailed history of past pregnancies, including spontaneous or elective abortions.

    • Number of living children and any history of child loss (SIDS, accident, disease, or relinquishment).

    • Previous pregnancy or childbirth complications.

    • Prior prenatal education.

Partner History and Patient Current Status

  • Partner’s History:

    • Age and occupation.

    • Use of alcohol, tobacco, or illicit drugs.

    • Blood type and Rh factor.

    • Thoughts and feelings regarding the current pregnancy.

    • Knowledge of genetic diseases in the partner's family.

  • Current Medical Status of the Mother:

    • Height, weight, and Body Mass Index (BMIBMI).

    • Blood type and Rh factor.

    • Current medications and allergies (food or medication).

    • Presence of chronic diseases (diabetes, hypertension, cardiac, etc.).

    • Current use of illicit drugs, tobacco, or alcohol.

    • Immunization record, with a specific focus on Rubella.

    • History of mental health conditions, such as depression or anxiety.

  • Current Pregnancy Details:

    • First day of the Last Menstrual Period (LMPLMP).

    • Intentionality of pregnancy (planned or unplanned).

    • Results of any completed pregnancy tests.

    • Current feelings and discomforts associated with the pregnancy.

    • Personal birth preferences and perceived educational needs.

Physical Examination and Baselines

  • Purpose: To establish a baseline of overall health and identify potential problems early.

  • Comprehensive Exam: A complete head-to-toe physical covering all major systems.

  • Pelvic Examination:

    • The patient is placed in the lithotomy position.

    • External Genitalia: Inspected for lesions or discharge indicative of STIsSTIs.

    • Internal Genitalia: Includes a Pap test for cervical cancer detection.

    • Bimanual Exam: Used to determine the size, position, consistency, and tenderness of the uterus and ovaries.

    • Pelvic Bones: Assessed to determine the size and adequacy of the pelvic outlet for a vaginal birth.

Laboratory and Diagnostic Testing

  • Initial Testing:

    • Complete Blood Count (CBCCBC) to monitor general health and check for anemia.

    • Antibody screen to determine if the mother has been exposed to fetal blood.

    • Blood Typing and Rh status.

    • Varicella titer and Rubella titer.

    • Tests for Hepatitis B, Hepatitis C, HIV, and STIsSTIs.

    • Pap test and Urinalysis.

    • Tuberculosis (TBTB) testing.

  • Later Testing (Second and Third Trimesters):

    • Repeat CBC.

    • Glucose Challenge: Conducted between 24 to 2824\text{ to }28\,weeks to screen for gestational diabetes. The patient is given 50 g50\,g of oral glucose. Blood glucose is checked after 1 hour1\,hour.

      • Normal result: <140 mg/dL< 140\,mg/dL.

      • If result is high: A 3-hour3\text{-}hour screening is required.

    • Group B Streptococci (GBSGBS) Test: Screening of the vagina and rectum for this normal flora. While usually asymptomatic in the mother, it can pass to the fetus during birth and cause severe health problems.

    • Rh Antibody Repeat: Monitored again later in pregnancy.

Special Screening: Rubella and Rh Sensitization

  • Rubella Immunity:

    • Tested early via rubella titer.

    • The virus causes congenital defects of the heart, hearing, and vision, especially if contracted in the first trimester.

    • Warning: Non-immune pregnant women cannot receive the vaccine during pregnancy. They must avoid foreign travel to areas with outbreaks, especially during the first trimester.

  • Antibody Screening and Rh Factor:

    • Detects antibodies that attack red blood cells.

    • Rh Sensitization: Occurs when an Rh-negativeRh\text{-}negative mother is pregnant with an Rh-positiveRh\text{-}positive fetus and fetal blood enters maternal circulation, causing the mother to produce antibodies.

    • These antibodies can destroy red blood cells in future pregnancies.

    • Screening is typically repeated at 2828 and 3636\,weeks’ gestation.

    • Treatment: RhoGAM is used to treat Rh-negativeRh\text{-}negative women exposed to Rh-positiveRh\text{-}positive blood.

Fetal Health and Trimester Testing

  • First Trimester (11 to 1311\text{ to }13\,weeks):

    • PAPP-A: Pregnancy-associated plasma protein-A to detect genetic abnormalities.

    • Fetal Ultrasonography: To determine fetal age.

    • Nuchal Translucency Testing: Screens for chromosomal abnormalities by measuring fluid accumulation in the fetal neck.

    • Chorionic Villus Sampling (CVSCVS): Invasive testing for genetic disorders.

    • Preimplantation Genetic Testing: Used for those with high risk of inheriting genetic disorders.

  • Second Trimester:

    • Quadruple Screen:

      1. Alpha-fetoprotein (AFPAFP): High levels suggest neural-tube defects; low levels suggest risk for Down syndrome (trisomy 21) or trisomy 18.

      2. hCG: High levels indicate risk for Down syndrome.

      3. Unconjugated Estriol (UEUE): Low levels indicate risk for Down syndrome.

      4. Inhibin-A: High levels indicate risk for Down syndrome.

    • Amniocentesis Risks: Spontaneous abortion, infection, fetal injury, amniotic fluid leakage, Rh sensitization, and transmission of infections (HIV, Hepatitis C, or Toxoplasmosis).

    • Percutaneous Umbilical Cord Sampling: Used for DNA studies, diagnosing hematological problems or infections, and evaluating fetal oxygenation.

Subsequent Prenatal Visits and Fetal Assessment

  • Visit Frequency:

    • Monthly for the first 2828\,weeks’ gestation.

    • Every 22\,weeks until 3636\,weeks’ gestation.

    • Weekly from 3636\,weeks until childbirth.

  • Standard Assessments during Visits:

    • Evaluation of physical and psychological concerns.

    • Weight monitoring for appropriate gain.

    • Vital signs monitoring, specifically for increasing Blood Pressure (BPBP).

    • Urinalysis.

    • Measurement of fundal height.

    • Monitoring Fetal Heart Rate (FHRFHR).

    • Screening for intimate partner violence (IPVIPV) and providing education.

  • Fetal Development Indicators:

    • Fetal Heart Rate (FHRFHR): Normal range is 110 to 160110\text{ to }160\,beats per minute (bpmbpm), usually measured by doppler. If not heard by 1212\,weeks, an ultrasound is performed.

    • Quickening: The first perception of fetal movement, expected between 16 to 2216\text{ to }22\,weeks. Primigravida women (first pregnancy) typically notice it later.

Safety Stat: Intimate Partner Violence (IPV)

  • Warning Signs:

    • Frequent late arrival or absence from prenatal appointments.

    • Injuries specifically to the face, head, neck, chest, or abdomen.

    • Unexplained vaginal bleeding or genitourinary infections.

    • Observable signs of anxiety, depression, or self-harm.

    • Signs of alcohol or substance use disorder.

    • The partner insists on attending every visit and answers all questions directed at the woman.

  • Nursing Action: Document all observations and information; report according to established agency policy.